Onishi Shumpei, Yamasaki Fumiyuki, Kinoshita Yasuyuki, Amatya Vishwa J, Takayasu Takeshi, Yonezawa Ushio, Taguchi Akira, Go Yukari, Takeshima Yukio, Horie Nobutaka
Department of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University.
Department of Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University.
Jpn J Clin Oncol. 2023 Oct 4;53(10):905-911. doi: 10.1093/jjco/hyad078.
Radiation-induced sarcoma (RIS) is among the neoplasms potentially caused by radiation therapy (RT) for brain tumors. However, the clinical characteristics of and ideal treatment for RIS are unclear. We analysed our case experience and conducted a comprehensive literature review to reveal the characteristics of brain and cranial RIS.
We analysed 165 cases of RIS from the literature together with the RIS case treated at our institution. In each case, the latency period from irradiation to the development of each RIS and the median overall survival (OS) of the patients was analysed by Kaplan-Meier analysis. Spearman's correlation test was used to determine the relationship between the latency period and radiation dose or age at irradiation.
The mean age at the development of RIS was 39.63 ± 17.84 years. The mean latency period was 11.79 ± 8.09 years. No factors associated with early development of RIS were detected. The median OS was 11 months, with fibrosarcoma showing significantly shorter OS compared with osteosarcoma and other sarcomas (p = 0.0021), and intracranial RIS showing a worse prognosis than extracranial RIS (p < 0.0001). Patients treated with surgery (p < 0.0001) and postoperative chemotherapy (p = 0.0157) for RIS presented significantly longer OS, whereas RT for RIS was not associated with a survival benefit.
Although prognosis for RIS is universally poor, pathological characteristics and locations are associated with worse prognosis. Surgery and chemotherapy may be the ideal treatment strategies for RIS.
放射性肉瘤(RIS)是脑肿瘤放射治疗(RT)可能引发的肿瘤之一。然而,RIS的临床特征及理想治疗方法尚不清楚。我们分析了自身的病例经验,并进行了全面的文献综述,以揭示脑部和颅部RIS的特征。
我们分析了文献中的165例RIS病例以及我院治疗的RIS病例。对每例病例,通过Kaplan-Meier分析来分析从放疗至各RIS发生的潜伏期以及患者的中位总生存期(OS)。采用Spearman相关性检验来确定潜伏期与放射剂量或放疗时年龄之间的关系。
RIS发病时的平均年龄为39.63±17.84岁。平均潜伏期为11.79±8.09年。未检测到与RIS早期发生相关的因素。中位OS为11个月,纤维肉瘤的OS显著短于骨肉瘤和其他肉瘤(p = 0.0021),颅内RIS的预后比颅外RIS差(p < 0.0001)。接受手术治疗(p < 0.0001)和术后化疗(p = 0.0157)的RIS患者的OS显著更长,而RIS的放疗未带来生存获益。
尽管RIS的预后普遍较差,但病理特征和部位与更差的预后相关。手术和化疗可能是RIS的理想治疗策略。